Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,699.38
(
1.01%
)
US TECH 100
23,958.40
(
-0.24%
)
Dow Jones
46,946.41
(
0.83%
)
Brent Oil
100.80
(
2.54%
)
Bitcoin
74,011.97
(
-1.11%
)
News Focus
News Focus
Post# of 257250
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122790
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ghmm post# 122084

Tuesday, 06/28/2011 8:15:48 AM

Tuesday, June 28, 2011 8:15:48 AM

Post# of 257250

…Humira [is] expected to be the biggest-selling medicine in 2012 with sales of $8.7bn. Humira is forecast to grow 5% annually to reach $9.7bn by 2016, almost $2bn higher than its nearest challenger, Roche's Avastin…

Source: EvaluatePharma (http://finance.yahoo.com/news/Humira-to-Assume-Lipitors-prnews-3889390601.html?x=0&.v=2 )

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now